Hearing News Watch

SEONGNAM, SOUTH KOREA — Rznomics Inc., a South Korea-based clinical-stage biopharmaceutical company, has entered a strategic global research and licensing agreement with Eli Lilly and Company to co-develop RNA-editing therapies for sensorineural hearing loss. The collaboration marks another major step in Lilly’s expanding footprint in the field of genetic hearing restoration. Under the agreement, Rznomics will lead early-stage discovery using

A secondary analysis of the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) trial suggests that hearing intervention may significantly slow cognitive decline in older adults—particularly those at greatest risk. The findings, published May 14, 2025, in Alzheimer’s & Dementia, show a 62% reduction in the rate of cognitive decline over three years among individuals with the highest predicted risk,

BLOOMINGTON, MINNESOTA – ReSound has announced the results of its annual Gift of Hearing campaign, during which 293 hearing care practices across the United States and Canada donated a total of 780 hearing aids to 390 people. Running from December 2024 through April 2025, this year’s initiative marked the campaign’s highest participation and impact since its launch in 2020. Since

EDEN PRAIRIE, MINNESOTA – Brandon Sawalich, President and CEO of Starkey, has been named Best MedTech Company CEO by the 2025 MedTech Breakthrough Awards. The annual awards program recognizes excellence and innovation across the global health and medical technology industry. Sawalich has served as Starkey’s President and CEO since 2017, leading the company through a period of strategic expansion and

STAEFA, SWITZERLAND – Sonova Holding AG announced its financial results for the fiscal year 2024/25, reporting growth across all four business segments and confirming a planned CEO transition. The company saw full-year sales of CHF 3.87 billion (~$4.26 billion USD), marking a 7.6% increase in local currencies and a 6.6% rise in Swiss francs. Adjusted EBITA grew 7.4% in local

IOWA CITY, IA — The University of Iowa has announced the upcoming 32nd annual Management of the Tinnitus & Hyperacusis Patient international conference, which is set to take place from August 14-15, both in-person and remotely. In-Person venue will be held at Wendell Johnson Speech & Hearing Center. The popular conference is intended for otologists, audiologists, psychologists, hearing aid specialists

LYNGE, DENMARK – WSA, a global hearing healthcare group, reported financial results for the second quarter of fiscal year 2024/25 (January 1–March 31, 2025), with organic revenue growth of 1% and a 22% increase in EBITDA. This reflects an improvement of 2.8 percentage points in the company’s EBITDA margin. “With an organic revenue growth of 1% in a volatile macro environment

LOS ANGELES, CALIFORNIA – An international research team led by Dr. Etan Orgel at Children’s Hospital Los Angeles (CHLA) has developed a machine learning model designed to estimate a child’s risk of developing hearing loss after receiving the chemotherapy drug cisplatin. The tool, known as PedsHEAR, was built using routinely available clinical information and has demonstrated 95% predictive accuracy. Results

A new study published in Science Translational Medicine has identified involuntary facial and eye responses that may serve as objective biomarkers of tinnitus-related distress. The findings, from researchers at Mass General Brigham, mark a potential breakthrough for advancing diagnostics and evaluating treatments for tinnitus, a condition that affects millions of people worldwide. The team, led by Dr. Daniel Polley of

AURORA, COLORADO – On Friday, June 28, the Department of Otolaryngology – Head and Neck Surgery at the University of Colorado Anschutz Medical Campus will host the Colorado Audiology Symposium at the Donald E. Elliman Conference Center, with hybrid attendance options available both in-person and virtually. The event will run from 8:00 a.m. to 3:00 p.m. and includes breakfast and